| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $0.49 (Beat by $0.07) |
| EPS GAAP Actual | $0.49 (Beat by $0.07) |
| Revenue Actual | $0.211447B |
| Revenue Surprise | Beat by $211.447M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 1 |
| Dec 2027 | 1 | 76.58 | 0.98946 | 1.01011 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.31 | -0.31 | 0.211447B | 3.66% | 211.45M |
| FQ2 2025 (Jun 2025) | 0.04 | 0.04 | 0.204678B | 3.21% | 204.68M |
| FQ1 2025 (Mar 2025) | 0.27 | 0.27 | 0.205936B | 10.13% | 205.94M |
| FQ4 2024 (Dec 2024) | -0.0803 | -0.0803 | 0.20854B | 6.35% | 208.54M |
| FQ3 2024 (Sep 2024) | -0.34 | -0.34 | 0.203698B | 14.36% | 203.7M |
| FQ2 2024 (Jun 2024) | 0.0431 | 0.0431 | 0.198114B | 20.99% | 198.11M |
| FQ1 2024 (Mar 2024) | -0.0921 | -0.0921 | 0.185074B | 100% | 185.07M |
| FQ4 2023 (Dec 2023) | 0.2 | 0.2 | 0.195292B | 100% | 195.29M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 0 |
| FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 0 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 0 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Dec 2026) | 0.63 | -- | 0.62643 | 0.63357 | 1 |
| FQ3 2026 (Sep 2026) | 0.56 | 155.36 | 0.55682 | 0.56318 | 1 |
| FQ2 2026 (Jun 2026) | 0.44 | 90.91 | 0.43668 | 0.44332 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.25B | -- | 0.25B | 0.26B | 1 |
| FQ3 2027 (Sep 2027) | 0.25B | -- | 0.25B | 0.25B | 1 |
| FQ2 2027 (Jun 2027) | 0.24B | -- | 0.24B | 0.24B | 1 |
| FQ1 2027 (Mar 2027) | 0.24B | -- | 0.24B | 0.24B | 1 |
| FQ4 2026 (Dec 2026) | 0.24B | -- | 0.24B | 0.24B | 1 |
| FQ3 2026 (Sep 2026) | 0.23B | 7.61 | 0.23B | 0.23B | 1 |
| FQ2 2026 (Jun 2026) | 0.22B | 6.02 | 0.22B | 0.22B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.31 | -0.31 | 100% | |
| FQ2 2025 (Jun 2025) | 0.04 | 0.04 | 100% | |
| FQ1 2025 (Mar 2025) | 0.27 | 0.27 | 100% | |
| FQ4 2024 (Dec 2024) | -0.0803 | -0.0803 | 100% | |
| FQ3 2024 (Sep 2024) | -0.34 | -0.34 | 100% | |
| FQ2 2024 (Jun 2024) | 0.0431 | 0.0431 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0921 | -0.0921 | 100% | |
| FQ4 2023 (Dec 2023) | 0.2 | 0.2 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0.21B | $211.45M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0.2B | $204.68M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.21B | $205.94M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.21B | $208.54M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.2B | $203.7M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.2B | $198.11M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.19B | $185.07M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.2B | $195.29M | 100% |